On the utility of CSF1R inhibitors
- 14 January 2021
- journal article
- letter
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 118 (4)
- https://doi.org/10.1073/pnas.2019695118
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- A Transgenic Line That Reports CSF1R Protein Expression Provides a Definitive Marker for the Mouse Mononuclear Phagocyte SystemThe Journal of Immunology, 2020
- CSF1R inhibition by a small-molecule inhibitor is not microglia specific; affecting hematopoiesis and the function of macrophagesProceedings of the National Academy of Sciences of the United States of America, 2020
- To Kill a Microglia: A Case for CSF1R InhibitorsTrends in Immunology, 2020
- Sustained microglial depletion with CSF1R inhibitor impairs parenchymal plaque development in an Alzheimer’s disease modelNature Communications, 2019
- Phenotypic impacts of CSF1R deficiencies in humans and model organismsJournal of Leukocyte Biology, 2019
- Deletion of a Csf1r enhancer selectively impacts CSF1R expression and development of tissue macrophage populationsNature Communications, 2019
- Microglia Dictate the Impact of Saturated Fat Consumption on Hypothalamic Inflammation and Neuronal FunctionCell Reports, 2014
- An antibody against the colony-stimulating factor 1 receptor depletes the resident subset of monocytes and tissue- and tumor-associated macrophages but does not inhibit inflammationBlood, 2010